TY - JOUR
T1 - A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+ CD34bright and AC133dim/-CD34+ human cord blood cells
AU - Goussetis, E.
AU - Theodosaki, M.
AU - Paterakis, G.
AU - Peristeri, J.
AU - Petropoulos, D.
AU - Kitra, V.
AU - Papassarandis, C.
AU - Graphakos, S.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2000
Y1 - 2000
N2 - The 5-transmembrane AC133 is expressed on a subpopulation of human hematopoietic cells that includes the CD34bright cells. We evaluated the development potential of AC133+CD34bright and AC133dim/-CD34+ cells isolated from 5 cord blood (CB) samples by studying the in vitro proliferative and differentiative potential of each population in both progenitor and mature cell expansion cultures. Seven-day culture of AC133+CD34bright cells with a cytokine combination favoring primitive progenitor cells causes a significant increase in CD34+, CFU-C and non-cycling stem/progenitor cells HPP-Q (High Proliferative Potential-Quiescent), whereas culture of AC133dim/-CD34+ cells shows a limited increase in committed progenitor cells only. HPP-Q cells were not found in freshly isolated AC133dim/-CD34+ nor in expanded CD34+ cells derived from AC133dim/-CD34+ cells. No statistically significant difference was observed between the 1-week expanded AC133+ and the initial AC133+CD34bright cells regarding their clonogenic efficiency (CE), while expanded CD34+ cells derived from AC133dim/-CD34+ cells exhibited a decreased CE. Subexpansion of the reselected AC133+ derived from AC133+CD34bright cells reveals a further increase of stem/progenitor cells and the 14-day expanded AC133+ cells reveal an unchanged CE. Subexpansion of reselected 7-day CD34+ cells derived from AC133dim/-CD34+ cells was not possible. Culture of AC133+CD34bright cells in cytokines that favor megakaryopoiesis or erythropoiesis resulted in a significant expansion of CD41+ and CD71+ cells, respectively; AC133dim/-CD34+, in comparison, showed a limited potential to megakaryocytic differentiation and a decreased production of erythroid cells. Our data indicate that early high proliferating stem/progenitor cells and early committed progenitors are present in AC133+CD34bright cells, but not in AC133dim/-CD34+ cells; the latter represent late committed progenitors with limited proliferative potential.
AB - The 5-transmembrane AC133 is expressed on a subpopulation of human hematopoietic cells that includes the CD34bright cells. We evaluated the development potential of AC133+CD34bright and AC133dim/-CD34+ cells isolated from 5 cord blood (CB) samples by studying the in vitro proliferative and differentiative potential of each population in both progenitor and mature cell expansion cultures. Seven-day culture of AC133+CD34bright cells with a cytokine combination favoring primitive progenitor cells causes a significant increase in CD34+, CFU-C and non-cycling stem/progenitor cells HPP-Q (High Proliferative Potential-Quiescent), whereas culture of AC133dim/-CD34+ cells shows a limited increase in committed progenitor cells only. HPP-Q cells were not found in freshly isolated AC133dim/-CD34+ nor in expanded CD34+ cells derived from AC133dim/-CD34+ cells. No statistically significant difference was observed between the 1-week expanded AC133+ and the initial AC133+CD34bright cells regarding their clonogenic efficiency (CE), while expanded CD34+ cells derived from AC133dim/-CD34+ cells exhibited a decreased CE. Subexpansion of the reselected AC133+ derived from AC133+CD34bright cells reveals a further increase of stem/progenitor cells and the 14-day expanded AC133+ cells reveal an unchanged CE. Subexpansion of reselected 7-day CD34+ cells derived from AC133dim/-CD34+ cells was not possible. Culture of AC133+CD34bright cells in cytokines that favor megakaryopoiesis or erythropoiesis resulted in a significant expansion of CD41+ and CD71+ cells, respectively; AC133dim/-CD34+, in comparison, showed a limited potential to megakaryocytic differentiation and a decreased production of erythroid cells. Our data indicate that early high proliferating stem/progenitor cells and early committed progenitors are present in AC133+CD34bright cells, but not in AC133dim/-CD34+ cells; the latter represent late committed progenitors with limited proliferative potential.
UR - http://www.scopus.com/inward/record.url?scp=0034489058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034489058&partnerID=8YFLogxK
U2 - 10.1089/152581600750062255
DO - 10.1089/152581600750062255
M3 - Article
C2 - 11177594
AN - SCOPUS:0034489058
SN - 1525-8165
VL - 9
SP - 827
EP - 840
JO - Journal of Hematotherapy and Stem Cell Research
JF - Journal of Hematotherapy and Stem Cell Research
IS - 6
ER -